SMTL ID : 6dbk.1

Tyk2 with compound 8

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x G5D: 4-({4-[(1S,4S)-5-(cyanoacetyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyrimidin-2-yl}amino)-N-ethylbenzamide(Non-covalent)

G5D.1: 22 residues within 4Å: Chain A: L.39, G.40, E.41, G.42, G.45, K.46, V.47, A.64, K.66, I.96, M.114, E.115, Y.116, V.117, P.118, G.120, D.124, R.163, N.164, L.166, G.176, D.177 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.39, A:V.47, A:I.96, A:Y.116, A:L.166, A:L.166 Hydrogen bonds: A:G.42, A:V.47, A:V.117, A:V.117 Water bridges: A:E.41

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fensome, A. et al., Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841). J. Med. Chem. (2018)

Release Date

2018-08-29

Peptides

Non-receptor tyrosine-protein kinase TYK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Non-receptor tyrosine-protein kinase TYK2

Related Entries With Identical Sequence